Effect on maximal mouth opening in children with spinal muscular atrophy treated with onasemnogene abeparvovec

被引：1
|
作者：
Beri, Nidhi [1 ]
Kapoor, Lekha [2 ]
Parashar, Deepak [3 ]
Mundada, Vivek [4 ]
机构：
[1] Aster DM Healthcare, Special Need Dent, Dubai, U Arab Emirates
[2] Aster DM Healthcare, ENT, Dubai, U Arab Emirates
[3] Univ Warwick, Dept Hlth Sci, Warwick Med Sch, Coventry, England
[4] Aster DM Healthcare, Paediat Neurol, Dubai, U Arab Emirates
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 2023年 / 108卷 / 10期
关键词：
Dentistry; Neurology;
D O I：
10.1136/archdischild-2023-325788
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：866 / 867
页数：2
相关论文
共 50 条
  • [1] Onasemnogene abeparvovec for the treatment of spinal muscular atrophy
    McMillan, Hugh J.
    Proud, Crystal M.
    Farrar, Michelle A.
    Alexander, Ian E.
    Muntoni, Francesco
    Servais, Laurent
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (09) : 1075 - 1090
  • [2] Onasemnogene Abeparvovec: A Review in Spinal Muscular Atrophy
    Hannah A. Blair
    [J]. CNS Drugs, 2022, 36 : 995 - 1005
  • [3] Onasemnogene Abeparvovec: A Review in Spinal Muscular Atrophy
    Blair, Hannah A.
    [J]. CNS DRUGS, 2022, 36 (09) : 995 - 1005
  • [4] Outcomes of Children Treated With Nusinersen/Onasemnogene Abeparvovec for Pediatric Spinal Muscular Atrophy Type 1
    Chacko, A.
    Sly, P. D.
    Gauld, L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [5] Epithelioid neoplasm of the spinal cord in a child with spinal muscular atrophy treated with onasemnogene abeparvovec
    Retson, Laura
    Tiwari, Nishant
    Vaughn, Jennifer
    Bernes, Saunder
    Adelson, P. David
    Mansfield, Keith
    Libertini, Silvana
    Kuzmiski, Brent
    Alecu, Iulian
    Gabriel, Richard
    Mangum, Ross
    [J]. MOLECULAR THERAPY, 2023, 31 (10) : 2991 - 2998
  • [6] Polysomnography findings in children with spinal muscular atrophy after onasemnogene-abeparvovec
    Leon-Astudillo, Carmen
    Wagner, Mary
    Salabarria, Stephanie M.
    Lammers, Jenna
    Berthy, Julie
    Zingariello, Carla D.
    Byrne, Barry J.
    Smith, Barbara K.
    [J]. SLEEP MEDICINE, 2023, 101 : 234 - 237
  • [7] Onasemnogene abeparvovec for spinal muscular atrophy: The costlier drug ever
    Mahajan, Rajiv
    [J]. INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2019, 9 (03) : 127 - 128
  • [8] An evaluation of onasemnogene abeparvovec for spinal muscular atrophy (SMN1)
    Waldrop, Megan A.
    Connolly, Anne M.
    Mendell, Jerry R.
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2021, 9 (7-10): : 199 - 204
  • [9] Onasemnogene-abeparvovec administration to premature infants with spinal muscular atrophy
    Brown, Stephen M.
    Ajjarapu, Aparna S.
    Ramachandra, Divya
    Blasco-Perez, Laura
    Costa-Roger, Mar
    Tizzano, Eduardo F.
    Sumner, Charlotte J.
    Mathews, Katherine D.
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024,
  • [10] Clinical Course in a Patient With Spinal Muscular Atrophy Type 0 Treated With Nusinersen and Onasemnogene Abeparvovec
    Matesanz, Susan E.
    Curry, Candace
    Gross, Brianna
    Rubin, Adam I.
    Linn, Rebecca
    Yum, Sabrina W.
    Kichula, Elizabeth A.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2020, 35 (11) : 717 - 723
12345